Aripiprazole for the Treatment of Antipsychotic-Induced Hyperprolactinemia in an Adolescent Boy.
1 Medical Scientist Training Program, University of Cincinnati , Cincinnati, Ohio.
Rebecca L
RL
Curran
2 Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center , Cincinnati, Ohio.
Ismail A
IA
Badran
2 Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center , Cincinnati, Ohio.
Virginia
V
Peppers
3 Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati , Cincinnati, Ohio.
Ernest V
EV
Pedapati
4 Department of Psychiatry and Molecular Medicine, Hofstra North Shore LIJ School of Medicine , Hempstead, New York.
Christoph U
CU
Correll
5 Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine , Cincinnati, Ohio.
Melissa P
MP
DelBello
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068180:Aripiprazole / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000188:drug therapy*; D008297:Male; D011388:Prolactin; D015363:Quinolones; D012559:Schizophrenia
D014150:Antipsychotic Agents; D015363:Quinolones; D000068180:Aripiprazole; D011388:Prolactin